Saving the spine without destroying the jaw

This episode provides a high level review of medication related osteonecrosis of the jaw tailored for practicing endocrinologists. The discussion anchors on current diagnostic criteria in patients utilizing antiresorptive or antiangiogenic therapies. Listeners will review the anatomical vulnerabilities of the mandible, multi factorial pathophysiology including osteoclast suppression and angiogenesis inhibition, and risk stratification across osteoporosis and oncology dosing regimens. Finally, the episode outlines preventative pre treatment protocols, the drug holiday debate, and conservative versus surgical management strategies.